Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958734 · ClinicalTrials.gov registry record · NA
Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1
A NA study of Cardiovascular Risk Factor and Lipemia, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT03958734: Completed NA study of Cardiovascular Risk Factor and Lipemia, sponsored by Virginia Commonwealth University.
NCT03958734 is a NA study of Cardiovascular Risk Factor and Lipemia that has completed, run by Virginia Commonwealth University. The registered enrollment target is 59 participants, below the 3,066-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03958734, a NA study of Cardiovascular Risk Factor and Lipemia, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.
Primary Outcome
Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans.
Conditions Studied
Interventions
- OTHER High-fat meal
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2021-04-29 |
| Phase | NA |
What the finished NCT03958734 record still lists
NCT03958734 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 3,066-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 1 intervention - of which High-fat meal is the first listed.
NCT03958734 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03958734 about?
NCT03958734 is a clinical study titled "Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1". The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.
What is the current status of trial NCT03958734?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2019-06-17. Estimated completion is 2021-04-29.
What conditions does trial NCT03958734 study?
This clinical trial studies the following conditions: Cardiovascular Risk Factor, Lipemia.
What interventions are being tested in trial NCT03958734?
The interventions under investigation include: High-fat meal (OTHER).
Who is sponsoring clinical trial NCT03958734?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03958734 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Risk Factor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03958734's enrollment target sits among peer trials
59 17th of 31 higher than 15 of 31 other Cardiovascular Risk Factor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Risk Factor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
Sleep Duration and Cardiovascular Health
RECRUITING · NA
-
The Potassium Supplementation Study
RECRUITING · NA
-
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
RECRUITING · NA
-
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI